Technologies, strategies and approaches for testing populations at risk of sexually transmitted infections: a systematic review protocol to inform prevention and control in EU/EEA countries

[1]  N. Low,et al.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016 , 2019, Bulletin of the World Health Organization.

[2]  R. Peeling,et al.  Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections , 2017, Sexually Transmitted Infections.

[3]  R. Peeling,et al.  Performance and operational characteristics of point-of-care tests for the diagnosis of urogenital gonococcal infections , 2017, Sexually Transmitted Infections.

[4]  Suzanna C Francis,et al.  Sexually transmitted infections: challenges ahead. , 2017, The Lancet. Infectious diseases.

[5]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[6]  J. McGowan,et al.  PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. , 2016, Journal of clinical epidemiology.

[7]  J. Klausner,et al.  A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis , 2016, Infectious diseases in obstetrics and gynecology.

[8]  Marleen Temmerman,et al.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.

[9]  A. Rowhani-Rahbar,et al.  Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Kaldor,et al.  Trichomonas vaginalis as a Cause of Perinatal Morbidity: A Systematic Review and Meta-Analysis , 2014, Sexually transmitted diseases.

[11]  Justin Hardick,et al.  Point of care diagnostics for sexually transmitted infections: perspectives and advances , 2014, Expert review of anti-infective therapy.

[12]  P. Kissinger,et al.  Trichomoniasis and HIV interactions: a review , 2013, Sexually Transmitted Infections.

[13]  C. Wiysonge,et al.  Topical microbicides for prevention of sexually transmitted infections. , 2012, The Cochrane database of systematic reviews.

[14]  E. Tacconelli.  Systematic reviews: CRD's guidance for undertaking reviews in health care , 2010 .

[15]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[16]  Maurine M Murtagh,et al.  The Point-of-Care Diagnostic Landscape for Sexually Transmitted Infections (STIs) , 2017 .

[17]  M. Mäkelä,et al.  Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA : A Member State survey of policies and practices in the prevention of mother-to-child transmission , 2016 .

[18]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[19]  R. Howell-Jones.  Novel approaches to testing for sexually transmitted infections, including HIV and hepatitis B and C in Europe , 2012 .

[20]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[21]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[22]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..